ST. LOUIS, April 12, 2018 /PRNewswire/ -- Guided by the principles of simplification, choice, and competition, Express Scripts (NASDAQ: ESRX) today announced the launch of a new, innovative 12-month ...
Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation IMULDOSA, a biosimilar to STELARA® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback